Armistice Capital Reports 9.99% Stake in Imunon, Inc. (IMNN)

On May 15, 2026, Armistice Capital, LLC and Steven Boyd filed a Schedule 13G/A disclosing a significant position in Imunon, Inc. (IMNN). As of the event date of March 31, 2026, the reporting persons beneficially own 396,718 shares of common stock, representing a 9.99% ownership stake in the company. This filing marks an increase from a previously reported 0.0% position. Armistice Capital, LLC serves as the investment manager for the Armistice Capital Master Fund Ltd., which is the direct holder of the shares. Steven Boyd, as the managing member of Armistice Capital, LLC, may be deemed to share voting and dispositive power over these securities. The filing specifies that the shares were acquired in the ordinary course of business and not for the purpose of influencing or changing the control of the issuer. The Master Fund retains the right to receive dividends and proceeds from the sale of the reported securities.